Dual targeting of CDK and tropomyosin receptor kinase families by the oral inhibitor PHA-848125, an agent with broad-spectrum antitumor efficacy
Molecular Cancer Therapeutics (2010) - Comment
pubmed: 20682657  doi: 10.1158/1535-7163.mct-10-0190  issn: 1538-8514  issn: 1535-7163 

Clara Albanese, Rachele Alzani, Nadia Amboldi, Nilla Avanzi, Dario Ballinari, Maria Gabriella Brasca, Claudio Festuccia, Francesco Fiorentini, Giuseppe Locatelli, Wilma Pastori, Veronica Patton, Fulvia Roletto, Francesco Colotta, Arturo Galvani, Antonella Isacchi, Jurgen Moll, Enrico Pesenti, Ciro Mercurio, Marina Ciomei